About this trial
This is a single-center prospective observational cohort study enrolling adult patients scheduled for cardiac surgery. Multi-timepoint clinical indicators, stool samples for gut microbiota and metabolomics profiling and artery blood will be collected before and after surgery. We aim to construct and validate a multi-dimensional preoperative predictive model for CSA-AKI based on clinical, microbial and metabolic signatures. Meanwhile, this research will explore the potential mediating role of the gut-kidney axis in the pathogenesis of cardiac surgery-associated acute kidney injury, and provide novel mechanistic evidence for early risk stratification and intervention of CSA-AKI.
Eligibility criteria
Qualifiers
Aged 18 years or older;
Scheduled for elective cardiac surgery;
Surgery performed under cardiopulmonary bypass (CPB);
Able to complete preoperative stool and blood sample collection independently;
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed